Bioharvest Sciences (BHST) Enterprise Value (2023 - 2025)
Bioharvest Sciences has reported Enterprise Value over the past 3 years, most recently at -$23.0 million for Q4 2025.
- Quarterly results put Enterprise Value at -$23.0 million for Q4 2025, down 863.39% from a year ago — trailing twelve months through Dec 2025 was -$23.0 million (down 863.39% YoY), and the annual figure for FY2025 was -$23.0 million, down 863.39%.
- Enterprise Value for Q4 2025 was -$23.0 million at Bioharvest Sciences, down from -$2.4 million in the prior quarter.
- Over the last five years, Enterprise Value for BHST hit a ceiling of -$2.4 million in Q4 2024 and a floor of -$23.0 million in Q4 2025.
- Median Enterprise Value over the past 3 years was -$5.4 million (2023), compared with a mean of -$10.3 million.
- Biggest five-year swings in Enterprise Value: surged 55.37% in 2024 and later plummeted 863.39% in 2025.
- Bioharvest Sciences' Enterprise Value stood at -$5.4 million in 2023, then surged by 55.37% to -$2.4 million in 2024, then plummeted by 863.39% to -$23.0 million in 2025.
- The last three reported values for Enterprise Value were -$23.0 million (Q4 2025), -$2.4 million (Q4 2024), and -$5.4 million (Q4 2023) per Business Quant data.